STLN analyst estimates

Starling Oncology (STLN) analyst ratings, the average price target and its range, and every firm's latest call.

• 4 firms rate STLN: 4 buy, 0 hold, 0 sell.
• The average price target is $9.00 from None analysts, from $9.00 to $9.00.

Updated 2026-11-11 00:47 UTC